Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TRANSGENE-4789/news/Transgene-and-BioInvent-Have-Enrolled-First-Patient-in-Phase-I-IIa-Trial-of-Novel-Oncolytic-Virus-32567898/?utm_source=whatsapp&utm_medium=social&utm_campaign=share